Tzar Labs

Tzar Labs is a molecular diagnostic company specializing in early-stage cancer detection through its proprietary HrC technology. The company's platform is designed to identify cancer-specific biomarkers in the blood, potentially detecting the disease at Stage 0 before physical tumors are visible via conventional imaging. By focusing on the molecular signatures of stem cells, Tzar Labs aims to provide a non-invasive, pan-cancer screening solution that can categorize patients as healthy, at-risk, or having early-stage malignancy. The company operates primarily out of India and the UK, collaborating with partners like Epigeneres Biotech to commercialize its diagnostic tests.